Morin (C5297): A High-Purity Natural Flavonoid Antioxidant for Disease Modeling and Mitochondrial Modulation

Executive Summary: Morin, chemically 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one, is a natural flavonoid isolated from Maclura pomifera with high-purity (≥96.81%) as provided by APExBIO (SKU C5297). It exhibits potent antioxidant, anti-inflammatory, cardioprotective, neuroprotective, and antimicrobial effects, primarily through inhibition of adenosine 5′-monophosphate deaminase and modulation of mitochondrial energy metabolism (Tee 2024). Morin is insoluble in water but dissolves in DMSO (≥19.53 mg/mL) and ethanol (≥6.04 mg/mL), making it suitable for a range of in vitro workflows. Its fluorescent chelating properties enable sensitive detection of aluminum ions in biochemical assays. Morin research supports disease modeling in diabetes, cancer, and neurodegenerative disorders, with proven stability at -20°C and batch-verified purity by HPLC, MS, and NMR (APExBIO).

Biological Rationale

Morin is a natural flavonoid antioxidant found in the fruit of Maclura pomifera. Its chemical identity is 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one, CAS number 480-16-0. Flavonoids are a class of polyphenolic compounds with established radical scavenging activity and cellular protection properties. Morin’s structure enables interaction with biological targets implicated in oxidative stress, mitochondrial dysfunction, and inflammation. These pathways are central to diabetes, cancer, and neurodegenerative diseases (see review). Morin has been shown to inhibit enzymes involved in nucleotide metabolism and modulate mitochondrial substrate utilization. Its biological rationale as a research tool is based on its ability to probe disease-relevant pathways with mechanistic specificity.

Mechanism of Action of Morin

Morin acts by multiple, well-characterized mechanisms:

• Antioxidant activity: Donates hydrogen atoms from phenolic hydroxyl groups to neutralize free radicals, reducing oxidative stress in cell and tissue models.
• Inhibition of adenosine 5′-monophosphate deaminase (AMPD): Suppresses AMPD activity, thereby enhancing mitochondrial ATP generation and energy metabolism (Tee 2024).
• Anti-inflammatory modulation: Downregulates pro-inflammatory cytokines and mediators, relevant in diabetes and neurodegenerative disease models.
• Cardioprotective and neuroprotective actions: Limits cellular injury via mitochondrial stabilization and reduced apoptosis.
• Fluorescent chelation: Forms stable fluorescent complexes with Al³⁺ ions, enabling its use as a selective probe in biochemical detection assays (APExBIO).

Morin’s multi-target mechanism is supported by in vitro and in vivo models using standardized concentrations and validated analytical techniques. For a detailed review of Morin’s mechanistic roles, see Morin as a Translational Catalyst, which this article extends by providing updated workflow integration details and recent evidence benchmarks.

Evidence & Benchmarks

• Morin inhibits adenosine 5′-monophosphate deaminase in cell-based assays, resulting in improved mitochondrial energy metabolism and enhanced ATP production under oxidative stress (Tee 2024).
• Morin demonstrates high radical-scavenging activity in DPPH and ABTS assays, with IC₅₀ values in the low micromolar range (benchmarked at pH 7.4, 25°C) (APExBIO).
• In animal models of diabetes and neurodegeneration, Morin administration reduces biomarkers of inflammation and cell death, improving functional outcomes (see Morin: Data-Driven Solutions for additional datasets).
• Morin forms highly fluorescent complexes with Al³⁺ at neutral pH, with detection limits below 1 μM, validated by spectrofluorometric analysis (APExBIO).
• Batch-tested purity (≥96.81%) is routinely validated using HPLC, MS, and NMR, supporting reproducibility in cell-based and biochemical assays (APExBIO).

Applications, Limits & Misconceptions

Morin’s primary applications include:

• Cell viability, proliferation, and cytotoxicity assays as a mitochondrial energy metabolism modulator.
• Fluorescent aluminum ion probe in analytical and environmental chemistry workflows.
• Mechanistic studies in models of diabetes, cancer, neurodegeneration, and inflammation.
• Use as a benchmark compound for antioxidant and anti-inflammatory screening.

Unlike Morin (C5297): Enhancing Cell-Based Assays, which focuses on experimental scenarios, this article clarifies physicochemical constraints and specific workflow requirements for accurate result interpretation.

Common Pitfalls or Misconceptions

• Morin is insoluble in water; use DMSO or ethanol as solvents to achieve precise dosing.
• Fluorescent detection is specific for Al³⁺; Morin is not a general probe for all metal ions.
• Stability is temperature-dependent; store solid at -20°C and avoid repeated freeze-thaw cycles for solutions.
• The anti-inflammatory and antioxidant effects are dose- and model-dependent; results may not extrapolate directly to human therapy.
• Morin is a research-use-only reagent and not approved for clinical or diagnostic applications.

Workflow Integration & Parameters

Morin (C5297, APExBIO) is supplied at ≥96.81% purity. Dissolve in DMSO (≥19.53 mg/mL) or ethanol (≥6.04 mg/mL) for in vitro use. Recommended working concentrations typically range from 1–50 μM for cellular assays, with solvent controls included. For fluorescent aluminum ion detection, prepare buffered solutions (pH 7.0–7.4) and calibrate using spectrofluorometric standards. Batch stability is optimal at -20°C; freshly prepare solutions for each experiment to ensure reproducibility. For detailed protocol scenarios and troubleshooting, see Morin: Translational Power, which this article updates by detailing new stability and solubility data.

Conclusion & Outlook

Morin (C5297) from APExBIO is a well-validated, high-purity natural flavonoid antioxidant with proven utility in disease modeling and mitochondrial function studies. Its mechanistic versatility and robust physicochemical properties make it an essential reagent for translational and analytical workflows. Ongoing research will refine its applications in neurodegenerative, diabetic, and cancer models, and develop novel bioanalytical uses for its fluorescent and chelating properties. Researchers are encouraged to consult both primary literature and validated product documentation for optimal experimental design.